CoChat

Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Suicide is a tremendous threat to global public health, and a large number of people who committed suicide suffered the pain of mental diseases, especially major depressive disorder (MDD). Previous study showed that ketamine could reduce suicidal ideation (SI), potentially by improving the impaired working memory (WM). The objective of current study was to illuminate the relationship between WM and SI in MDD with repeated ketamine treatment. MDD patients with SI (n = 59) and without SI (n = 37) completed six intravenous infusions of ketamine (0.5 mg/kg over 40 min) over 12 days (Day 1, 3, 5, 8, 10 and 12). The severity of depressive symptoms, SI and WM were assessed at baseline, day 13 and day 26. We found that WM was significantly improved after 6 ketamine infusions (F = 161.284, p = 0.009) in a linear mixed model. Correlation analysis showed that the improvement of depressive symptom was significantly associated with WM at baseline (r = - 0.265, p = 0.042) and the reduction in SSI-part I was related to the change of WM (r = 0.276, p = 0.034) in the MDD patients with SI. Furthermore, Logistic regression analysis showed that improvement in WM might predict the anti-SI response of ketamine. Our findings suggest that the improvement of working memory may partly account for the anti-SI effect of ketamine, and intervention of improving working memory function may be capable of reducing suicidal ideation.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00406-020-01221-z

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. Phillips JL, Norris S, Talbot J, Hatchard T, Ortiz A, Birmingham M, Owoeye O, Batten LA, Blier P (2020) Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology 45:606–612 · DOI · Paper page

Cited by

See all 27

Metadata

Authors
Chen, X., Wang, M., Hu, Y., Zhan, Y., Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhong, X., Li, H., Lan, X., Ning, Y., & Zhang, B.
Affiliations
Guangzhou Medical University (CN)
Corresponding author
Ning, Yuping
Venue
European Archives of Psychiatry and Clinical Neuroscience
Published
2021-01-01
Volume
271
Issue
3
Pages
431-438
ISSN
  • 0003-9373 (ISSN-L)
  • 0940-1334
  • 1433-8491
OpenAlex
W3113943946
Cited by
27
References
47
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 6
FWCI
3.07
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Science Foundation of China (81701341,81801345,81801343)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
ketamine, working memory, suicidal ideation, major depressive disorder, depressive symptoms, treatment response prediction
MeSH terms
Adult, Antidepressive Agents, Major Depressive Disorder, Female, Humans, Infusions, Intravenous, Ketamine, Male, Memory, Short-Term, Middle Aged, Receptors, N-Methyl-D-Aspartate, Outcome Assessment, Health Care, Excitatory Amino Acid Antagonists, Young Adult, Suicidal Ideation, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients. https://app.cochat.ai/papers/10.1007/s00406-020-01221-z
The paper
Chen, X., Wang, M., Hu, Y., Zhan, Y., Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhong, X., Li, H., Lan, X., Ning, Y., & Zhang, B. (2021). Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-020-01221-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.